Help your patients with EPI due
to CF or other conditions

Grab Life
by the Fork

CF=cystic fibrosis; EPI=exocrine pancreatic insufficiency.

CF=cystic fibrosis; EPI=exocrine pancreatic insufficiency.

symptoms icon

ZENPEP® was shown to
help improve nutrient absorption1,2


symptoms icon

ZENPEP offers the highest
strength capsule available, 40,000 lipase units, as well as the widest range of dosing1

Body Illustration

Beads and microbeads are designed to protect and deliver enzymes to the neutralized chyme within the proximal small intestine to enhance nutrient absorption1,3-5

Z-Save® Logo

ZENPEP CF Patient Support Program

Over 9 out of 10 patients are covered for ZENPEP6

-ZENPEP insurance coverage through commercial is 92% and through Medicare Part D is 95%6

-88% of patients have no prior authorization or step-edit requirements7

-Coverage is the same for all dosage strengths7*

*Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. Nestlé Health Science does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.

References: 1. ZENPEP. Package insert. Nestlé Health Science; 2020. 2. Wooldridge JL, Heubi JE, Amaro-Galvez R, et al. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency. J Cyst Fibros. 2009;8(6):405-417. doi:10.1016/j.jcf.2009.07.006 3. Karnik NP, Jan A. Pancrelipase. NCBI Bookshelf. Updated April 21, 2020. Accessed November 9, 2020. www.ncbi.nlm.nih.gov/books/NBK534847 4. Data on File. ZENPEP Dossier. 2014. 5. Data on File. Shape Patent. 2010. 6. MMIT Data on File. Nestlé Health Science. Accessed February 1, 2021. 7. MMIT Data on File. Nestlé Health Science. Accessed November 3, 2020.